Tag Archives: Jason Shandell

The President and General Counsel of Amphastar Pharmaceuticals (NASDAQ: AMPH) is Selling Shares

Today, the President and General Counsel of Amphastar Pharmaceuticals (AMPH – Research Report), Jason Shandell, sold shares of AMPH for $114.5K. Following Jason Shandell’s last AMPH Sell transaction on June 01, 2017, the stock climbed by 6.8%. See today’s analyst